祛瘀舒痞汤联合常规西药治疗慢性萎缩性胃炎癌前病变临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R573.3

基金项目:


Clinical Study on Quyu Shupi Decoction Combined with Routine Western Medicine for Precancerous Lesions of Chronic Atrophic Gastritis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察祛瘀舒痞汤联合常规西药治疗慢性萎缩性胃炎癌前病变的临床疗效。方法:选取慢性 萎缩性胃炎癌前病变患者132 例,按随机数字表法分为观察组和对照组各66 例。对照组采用14 d 序贯疗法, 观察组在对照组基础上给予祛瘀舒痞汤治疗。评价2 组临床疗效,比较2 组治疗前后中医证候评分、病理组织 评分,检测胃液中亚硝酸盐、乳酸、游离酸、总酸及胃泌素(GAS)、血清胰蛋白酶原2(TAT-2)、胃蛋白酶 原(PG)、高尔基体蛋白(GP73) 水平,比较2 组用药安全性。结果:观察组总有效率为78.79%,高于对照 组60.61%,差异有统计学意义(P<0.05)。治疗后,2 组各项中医证候评分均低于治疗前,且观察组各项中医 证候评分低于对照组,差异均有统计学意义(P<0.05)。治疗后,2 组异型增生、萎缩、炎症及肠生化评分较 治疗前降低,且观察组各项评分低于对照组,差异均有统计学意义(P<0.05)。治疗后,2 组GAS、PGⅠ、 PGⅡ水平较治疗前升高,TAT-2 及GP73 水平较治疗前降低,且观察组GAS、PGⅠ、PGⅡ水平高于对照组, TAT-2、GP73 水平低于对照组,差异均有统计学意义(P<0.05)。治疗后,2 组亚硝酸盐及乳酸水平均降低, 游离酸及总酸水平均升高,且观察组亚硝酸盐及乳酸水平低于对照组,游离酸及总酸水平高于对照组,差异均 有统计学意义(P<0.05)。结论:祛瘀舒痞汤联合常规西药治疗慢性萎缩性胃炎癌前病变疗效显著,能有效改 善患者临床症状及胃部病理情况,改善胃液酸碱度。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Quyu Shupi Decoction combined with routine western medicine for precancerous lesions of chronic atrophic gastritis. Methods:A total of 132 cases of patients with precancerous lesions of chronic atrophic gastritis were selected and divided into the observation group and the control group according to the random number table method,with 66 cases in each group. The control group was given 14- day sequential therapy, and the observation group was additionally treated with Quyu Shupi Decoction based on the treatment of the control group. The clinical effects in the two groups were evaluated; traditional Chinese medicine (TCM) syndrome scores and histopathological scores before and after treatment were compared between the two groups;the levels of nitrite, lactic acid, free acid, total acid and gastrin (GAS) in gastric juice, and trypsinogen 2 (TAT- 2), pepsinogen (PG) and Golgi protein (GP73) in serum were detected;the medication safety was compared between the two groups. Results:The total effective rate was 78.79% in the observation group,higher than that of 60.61% in the control group,the difference being significant (P<0.05). After treatment,TCM syndrome scores in the two groups were decreased when compared with those before treatment,and the scores in the observation group were lower than those in the control group,differences being significant (P<0.05). After treatment,the scores of dysplasia,atrophy,inflammation and intestinal biochemistry in the two groups were decreased when compared with those before treatment, and the scores in the observation group were lower than those in the control group,differences being significant (P<0.05). After treatment,the levels of GAS,PGⅠand PGⅡ in the two groups were increased when compared with those before treatment,and the levels of TAT-2 and GP73 were decreased;the levels of GAS,PGⅠ and PGⅡ in the observation group were higher that in the control group, and the levels of TAT- 2 and GP73 were lower than that in the control group,differences being significant (P<0.05). After treatment,the levels of nitrite and lactic acid in the two groups were decreased, and the levels of free acid and total acid were increased;the levels of nitrite and lactic acid in the observation were lower than that in the control group, and the levels of free acid and total acid were higher than that in the control group, differences being significant (P<0.05). Conclusion: Quyu Shupi Decoction combined with routine western medicine has a significant curative effect in the treatment of precancerous lesions of chronic atrophic gastritis,which can effectively improve the clinical symptoms,gastric pathological conditions,and the pH value of gastric fluid.

    参考文献
    相似文献
    引证文献
引用本文

郭洁,方玲,田春阳.祛瘀舒痞汤联合常规西药治疗慢性萎缩性胃炎癌前病变临床研究[J].新中医,2023,55(5):167-171

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-03-15
  • 出版日期:
文章二维码